Neuralink is a neurotechnology company that has been developing brain-machine interface technology. The company has developed a state-of-the-art neural implant called the Neuralink device. This tiny, flexible implant is designed to be implanted within the brain, connecting individual neurons with external computing devices. The company intends to bridge the gap between humans and machines by developing high-bandwidth brain-machine interfaces, “achieve a sort of symbiosis with artificial intelligence” and possibly enable telepathic communication with the device.
Neuralink raised $280 million in a Series D round led by Peter Thiel’s Founders Fund.
Neuralink, Fremont, California, United States, was founded in 2016 by Elon Musk and Max Hodak. Neuralink’s ultimate goal is to enhance human cognition, alleviate neurological disorders, and unlock the potential of the human brain. “Excited to support Neuralink’s next chapter of helping human patients in need. The team has been working for seven years to make this possible, pulling off technical breakthroughs that feel like science fiction. The chance to work with world-class teams accelerating a positive future is why I’m an investor, and even in that category Neuralink is special,” noted Founders Fund partner Scott Nolan.
